SCHEMBL5835198

SCHEMBL5835198

CCCCOC(=O)N(C(=O)Nc1ccc(N(CC)CC)cc1)C1CCc2ccccc2C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 3/20 0.55
NPY5R Q15761 2/20 0.51
RAB9A P51151 3/20 0.41
NPC1 O15118 2/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
MCL1 Q07820 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NOX1 Q9Y5S8 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HTR1A P08908 1/20 0.39
MCHR1 Q99705 1/20 0.38
GCGR P47871 1/20 0.38
CFTR P13569 1/20 0.37
TAOK1 Q7L7X3 2/20 0.37
TAOK3 Q9H2K8 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5835266 0.97 GHSR (0.54) GHSRNPY5RRAB9ANPC1MAPT
SCHEMBL5835115 0.96 GHSR (0.53) GHSRNPY5RRAB9ANPC1MAPT
SCHEMBL5835382 0.94 GHSR (0.57) GHSRNPY5RRAB9ANPC1MAPT
SCHEMBL5834913 0.93 GHSR (0.53) GHSRNPY5RRAB9ANPC1MAPT
SCHEMBL5835311 0.91 GHSR (0.55) GHSRNPY5RRAB9ANPC1MAPT
SCHEMBL5834802 0.90 GHSR (0.59) GHSRNPY5RRAB9ANPC1MAPT
SCHEMBL5834823 0.89 GHSR (0.56) GHSRNPY5RRAB9ANPC1MAPT
SCHEMBL5834803 0.88 GHSR (0.52) GHSRNPY5RRAB9ANPC1MAPT
SCHEMBL5834787 0.87 GHSR (0.55) GHSRNPY5RRAB9ANPC1MAPT
SCHEMBL5834860 0.87 GHSR (0.55) GHSRNPY5RRAB9ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US claimed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US claimed
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US disclosed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators GPR119, GHSR, GIPR GHSR 2/4885NPY5R 43/4885RAB9A 1199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.